Fundamental dimension Equity attribute | CHTPeer $48.56▼-0.34% Cap $37.67BP/E 35.5x QuantScore45/100 | 3045.TWPeer —— Cap —P/E — QuantScore— | AMXLeader $24.66▼-1.30% Cap $73.62BP/E 15.0x QuantScore60/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical Trend, RSI, MACD & signal consensus | |||
73/100 |
— |
75/100 |
Valuation Multiples, PEG & DCF upside | 67/100 | — | 99/100 |
Health Piotroski, Altman Z, leverage & liquidity | 68/100 | — | 21/100 |
Growth Revenue / earnings growth & margins | 18/100 | — | 42/100 |
Sentiment Analyst ratings, targets & revisions | 0/100 | — | 63/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 35.5x | — | 15.0x |
Forward P/E (next FY) | 0.9x | — | 0.8x |
EV / EBITDA (TTM) | 16.4x | — | 5.2x |
Price / Sales | 5.8x | — | 1.4x |
Price / Free Cash Flow | 22.2x | — | 9.4x |
PEG ratio | -3.52 | — | 0.59 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 4 / 9 | — | 7 / 9 |
Altman Z-Score | 5.19 (Safe) | — | 1.83 (Grey) |
Total debt / equity | 0.10 | — | 1.75 |
Quick ratio | 1.1x | — | 0.7x |
Interest coverage | 143.8x | — | 3.6x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +2.7% | — | +1.8% |
Net income growth YoY | +4.1% | — | +239.2% |
Gross margin (TTM) | 30.3% | — | 53.4% |
Operating margin (FY) | 20.7% | — | 21.0% |
FCF margin (FY) | 21.1% | — | 13.6% |
5. Trailing price performancePrice change over period |
1M return | +5.3% | — | +11.4% |
3M return | +13.5% | — | -5.5% |
6M return | +12.7% | — | -7.8% |
Year to date | +16.3% | — | +18.9% |
1Y return | +12.0% | — | +8.4% |
3Y return | +35.2% | — | +45.9% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $51.71 +6.5% upside | — — | $49.29 +99.9% upside |
Wall Street consensus target | — — | — — | $29.12 +18.1% · range $20.80–$35.00 |
Consensus stance | 25% Buy25% Hold50% Sell | — | 50% Buy38% Hold13% Sell |